Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - AVANIR PHARMACEUTICALS, INC. | d259667d10k.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex311.htm |
| EX-10.24 - FORM OF CHANGE OF CONTROL AGREEMENT - AVANIR PHARMACEUTICALS, INC. | d259667dex1024.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex312.htm |
| EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex322.htm |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex321.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AVANIR PHARMACEUTICALS, INC. | Financial_Report.xls |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-83089, 333-84183, 333-38094, 333-108716, 333-125743, 333-144221, 333-150253, 333-158595, 333-166067 and 333-173206 on Form S-8 and Registration Statement Nos. 333-34958, 333-149125, 333-158665 and 333-161789 on Form S-3 of our report dated December 13, 2011, relating to the consolidated financial statements of Avanir Pharmaceuticals, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of Avanir Pharmaceuticals, Inc. for the year ended September 30, 2011.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
December 13, 2011